Celexa and Memantine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Memantine (memantine). Common drug interactions include vitreous floaters among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Memantine. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.



On Jul, 27, 2026

37 people who take Celexa and Memantine together, and have interactions are studied.

Celexa and Memantine drug interactions.

What are the common drug interactions of Celexa and Memantine, by gender? *:

female:

  1. Vitreous floaters (spots before the eyes)
  2. Weight decreased
  3. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  4. Ageusia (loss of taste functions of the tongue)
  5. Fatigue (feeling of tiredness)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Memory impairment
  8. White blood cell count increased
  9. Decreased appetite
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Acute respiratory failure
  5. Aggression
  6. Asthenia (weakness)
  7. Cerebral disorder (brain disease)
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  10. Hallucination, visual (seeing things that aren't there)

What are the common drug interactions of Celexa and Memantine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dry eye (lack of adequate tears)
  2. Dry mouth
  3. Fatigue (feeling of tiredness)
  4. Fibromyalgia (a long-term condition which causes pain all over the body)
  5. Gastric disorder (disease of stomach)
  6. Insomnia (sleeplessness)
  7. Pain
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Teeth brittle (other half has a defect in the teeth)

40-49:

  1. Gait disturbance
  2. Memory impairment
  3. Vision blurred

50-59:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Peripheral swelling
  4. Renal cancer stage ii (the tumour is larger than 7 cm and is in the kidney only. it has not spread to the lymph nodes)
  5. Urinary tract infection
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Acute respiratory failure
  9. Aggression
  10. Anaemia (lack of blood)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 18.92%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 13.51%
  3. Multiple Myeloma (cancer of the plasma cells): 5 people, 13.51%
  4. Immunodeficiency Common Variable: 4 people, 10.81%
  5. Dementia (madness): 4 people, 10.81%
  6. Stress And Anxiety: 4 people, 10.81%
  7. Dementia With Lewy Bodies (progressive degenerative disease or syndrome of the brain): 3 people, 8.11%
  8. Parkinson's Disease: 3 people, 8.11%
  9. High Blood Cholesterol: 3 people, 8.11%
  10. Weakness: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Memantine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celexa and Memantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Memantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Memantine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and memantine (the active ingredients of Celexa and Memantine, respectively), and Celexa and Memantine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: